Health Trials

B-Cell Lymphoproliferative Disorder

2

Review clinical trials related to B-Cell Lymphoproliferative Disorder. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Epcoritamab in Previously Treated WM

This study is being done to determine if epcoritamab can be used to treat participants with previously treated Waldenstrom Macroglobulinemia (WM). The names of the study drug involved in this study is: -Epcoritamab (a type of antibody)

Participants needed: 20
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Gottfried von Keudell, MD PhDUpdated: Mar 13, 2026Locations: 3
Eligibility criteria

A diagnosis of lymphoplasmacytic lymphoma/WM that is CD20+ by immunophenotype or... [+25]

Participants who have disease that has transformed to aggressive lymphoma [+16]

Read more
Status: Recruiting

A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia

This study is being done to examine the safety and effectiveness of pacritinib as a possible treatment for participants with Waldenström macroglobulinemia (WM). The name of the study drug involved in this study is: -Pacritinib (a type of kinase inhibitor)

Participants needed: 30
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Shayna Sarosiek, MDUpdated: Dec 5, 2025Locations: 1
Eligibility criteria

Age ≥18 years [+20]

Current history of uncontrolled HIV [+21]

Read more